Epi-pens are all the rage for treating allergic shock reactions for bee stings and dietary concerns.
But, there's nothing so simple for treating a low blood sugar that leaves someone unresponsive and unable to consume sugar. Our only option at that point is an injection of Glucagon - an expensive drug that has to be mixed before it can be injected. Many schools will refuse to administer it due to the complexity of the process! (some also claim the risks of injection are too high, but that idiocy is a discussion for a different day...)
Along comes the Xeris G-Pen
It has a new chemical solution that keeps Glucagon stable and ready for injection for up to 2 years. Combine that with the ability to inject measured doses and it's looking like a 1-2-Win for the diabetes community.
Where is it at now? As of June 4th, 2013, it has passed animal trials and is on-track for Q3 clinical trials at the Texas Diabetes Institute in San Antonio.
Fingers are crossed for a 2015 launch!